Skip to content
Dosage GuideResearch Reference

Cardiogen Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Cardiogen. All information is for educational purposes only.

Quick Answer

Cardiogen is a research peptide with limited human data. Preclinical studies have used a wide range of dosages, but no standardized therapeutic dose exists. The following information is for research purposes only and should not be interpreted as a recommendation for human use.

→ Cardiogen Benefits→ Cardiogen Side Effects→ Full Cardiogen Profile
Table of Contents

Standard Dosage Range

Research dosing range: 10–100 mcg (preclinical research range)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Cardioprotection (preclinical models)

10–50 mcg1× daily
Duration

4–8 weeks

Based on animal studies evaluating cardiomyocyte survival. Route of administration varies in research (subcutaneous, intraperitoneal). No established human equivalent dose.

Oxidative Stress Reduction (preclinical models)

20–100 mcg1× daily
Duration

4–8 weeks

Doses used in animal studies showing reductions in oxidative stress markers in cardiac tissue. No human dose-ranging studies available.

Gene Expression Modulation (research settings)

10–50 mcg1× daily
Duration

Variable (research-dependent)

Used in cell culture and animal models to study effects on cardiac-specific gene expression. Route and duration are dependent on the specific research protocol.

Timing & Frequency

Due to the lack of human data, there is no established optimal timing for Cardiogen administration. In preclinical studies, it is typically administered once daily.

Cycle Guidance

Cardiogen is primarily a research compound. Cycling protocols are based on preclinical study designs. A common approach is 4–8 weeks followed by a period of rest.

Reconstitution Reference

Quick reference for reconstituting Cardiogen. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeVariable (research-dependent)
BAC Water VolumeDependent on vial size and desired concentration
Concentration & DrawDependent on vial size and water volume. Example: 1 mg in 1 mL water yields 1 mcg per microliter.
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stability depends on storage conditions. Lyophilized powder stable 12-24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the appropriate dosage of Cardiogen for heart health?
Cardiogen is a research compound. No human clinical trials have established a safe and effective dosage for any condition. The information provided here is for informational purposes only and is not a recommendation for human use. Consult with a qualified healthcare professional before using any peptide.
How long should I cycle Cardiogen?
Due to limited human data, there is no established cycling protocol for Cardiogen. Preclinical studies often use 4–8 week protocols. Cycling rationale is primarily precautionary given limited long-term human safety data.
What is the best way to administer Cardiogen?
Routes of administration used in preclinical studies include subcutaneous and intraperitoneal injection. There is no established optimal route of administration for humans. Consult with a qualified healthcare professional.

Last updated: 2026-02-19